The evaluation and management of patients with occult bacteremia is co
ntroversial. The purpose of this study was to define the prevailing pr
actices in the emergency management of occult bacteremia. Short, anony
mous surveys were mailed to all 517 members of the Section on Emergenc
y Medicine at the American Academy of Pediatrics. Three hundred six (5
9%) of those surveyed returned completed questionnaires. Eleven differ
ent temperature cutoff points are used, and 105 (34%) consider occult
bacteremia in patients with temperature above 39-degrees-C. Seventeen
different age intervals are used to define the patients at risk for oc
cult bacteremia, and the age range three to 24 months is used by 173 (
57%) of those surveyed. Complete blood cell count is the most commonly
used screening test; it is routinely ordered by 225 respondents (74%)
. One hundred thirty-seven participants (45%) routinely obtain blood c
ultures in all patients at risk for occult bacteremia, whereas 111 (36
%) use the clinical appearance (toxicity) of the patient to determine
whether a blood culture should be drawn. One hundred sixty-one (53%) o
f those surveyed routinely administer antibiotics to toxic-appearing p
atients pending the results of the blood culture. Laboratory criteria
are used by 135 (44%) in the decision whether to administer empiric an
tibiotics. Ceftriaxone is the most commonly used antibiotic; it is rou
tinely administered by 230 respondents (75%). Twenty participants (7%)
routinely admit all patients with Streptococcus pneumoniae, whereas 2
17 (71%) admit all patients with Haemophilus influenzae bacteremia and
234 (76%) admit all patients with Neisseria meningitidis bacteremia.
We conclude that diversity exists in the evaluation and management of
occult bacteremia.